Search research articles
Contact Us
Filters
Showing results (31-40 of 1,747) with videos related to
Page
of 175
Sort By:
European Urology
|
October 2, 2021
Re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72
Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
The Lancet. Oncology
|
October 22, 2021
Reimagining prostate cancer screening: the IMPACT of germline mutations
Giorgio Gandaglia, Alberto Briganti, Francesco Montorsi
The Journal of Urology
|
October 25, 2019
Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial
Francesco Montorsi, Marco Moschini, Alberto Briganti
European Urology
|
April 12, 2008
Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values
Felix K-H Chun, Alberto Briganti
The Journal of Urology
|
April 22, 2025
Letter: A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation
Francesco Montorsi, Armando Stabile, Alberto Briganti
European Urology
|
October 16, 2018
Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO)
Andrea Necchi, Antonella Messina, Alberto Briganti
The Lancet. Oncology
|
December 17, 2008
The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer
Alberto Briganti, Patrizio Rigatti, Francesco Montorsi
JAMA
|
August 21, 2014
Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer
Fabio Castiglione, Francesco Montorsi, Alberto Briganti
BJU International
|
November 11, 2014
Long-term outcomes of robot-assisted radical prostatectomy: Where do we stand?
Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
European Urology
|
December 4, 2014
Re:Mark K. Buyyounouski. Radiobiological modeling and the study of hypofractionated radiotherapy for prostate cancer. Eur Urol 2014;66:1031-2
Claudio Fiorino, Alberto Briganti, Cesare Cozzarini
Page
of 175
Search research articles
Search
Showing results (31-40 of 1,747) with videos related to
Sort By:
Page
of 175
European Urology
|
October 2, 2021
Re: Andrew J. Vickers. Effects of Magnetic Resonance Imaging Targeting on Overdiagnosis and Overtreatment of Prostate Cancer. Eur Urol 2021;80:567-72
Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
The Lancet. Oncology
|
October 22, 2021
Reimagining prostate cancer screening: the IMPACT of germline mutations
Giorgio Gandaglia, Alberto Briganti, Francesco Montorsi
The Journal of Urology
|
October 25, 2019
Re: Evaluation of the Fluorescence In Situ Hybridization Test to Predict Recurrence and/or Progression of Disease after bacillus Calmette-Guérin for Primary High Grade Nonmuscle Invasive Bladder Cancer: Results from a Prospective Multicenter Trial
Francesco Montorsi, Marco Moschini, Alberto Briganti
European Urology
|
April 12, 2008
Editorial comment on: preliminary results of a novel method to estimate the probability of prostate cancer in men with elevated serum PSA values
Felix K-H Chun, Alberto Briganti
The Journal of Urology
|
April 22, 2025
Letter: A Multi-Institutional Study of Magnetic Resonance/Ultrasound Fusion-Guided Nanoparticle-Directed Focal Therapy for Prostate Ablation
Francesco Montorsi, Armando Stabile, Alberto Briganti
European Urology
|
October 16, 2018
Re: Valeria Panebianco, Yoshifumi Narumi, Ersan Altun, et al. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306: Validating VI-RADS Criteria Within Immune-oncology Strategies (VI-RADS-IO)
Andrea Necchi, Antonella Messina, Alberto Briganti
The Lancet. Oncology
|
December 17, 2008
The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node metastases in prostate cancer
Alberto Briganti, Patrizio Rigatti, Francesco Montorsi
JAMA
|
August 21, 2014
Tadalafil for erectile dysfunction prevention after radiotherapy for prostate cancer
Fabio Castiglione, Francesco Montorsi, Alberto Briganti
BJU International
|
November 11, 2014
Long-term outcomes of robot-assisted radical prostatectomy: Where do we stand?
Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti
European Urology
|
December 4, 2014
Re:Mark K. Buyyounouski. Radiobiological modeling and the study of hypofractionated radiotherapy for prostate cancer. Eur Urol 2014;66:1031-2
Claudio Fiorino, Alberto Briganti, Cesare Cozzarini
Page
of 175